Victoria's Secret (VSXY)

NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-10-15

$87.34-3.52%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge Victoria's Secret’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

0.0%

+10% or more+5%0%−5%−10% or less

5.62 → 5.62 EPS · FY ending Jan 31, 2028 · 6 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 6; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
EPS grows to at least $4.59 in FY27	A supporting condition in Victoria's Secret's published investment case. The stated target is >=4.59 USD_PER_SHARE.	Intact	EPS falls below $2.33 in FY27	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Successful execution of growth plans including new outlets	The company has strong leadership and a clear growth plan with new outlets.	Improving	Failure to advance outlet plans or loss of board control	9.0% comp sales growth vs qualitative expansion target Q2 earnings beat, 9% comp sales growth, and raised FY26 sales guidance to $7.10-$7.18B confirm advancing execution. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Operating profit near $565 million in FY27	Profit is rising with operating margin expected near $565 million.	Intact	Operating margin falls below $265 million in FY27	Operating margin: 15.95% FY2026-Q2; GAAP. Published target: 550-580 USD_MILLIONS. Target percentage unit is not explicit. Source published Sep 4, 202615.952824 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 2270d958-8c40-4649-96ab-ca716c957e74. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue grows to at least $7.03 billion in FY27	A primary condition in Victoria's Secret's published investment case. The stated target is >=7.03 USD_BILLIONS.	Intact	Revenue falls below $6.37 billion in FY27	Revenue: $1.611B FY2026-Q2; GAAP. Published target: >=7.03 USD_BILLIONS. Target period is not explicitly aligned with this observation. Source published Sep 4, 20261,611,000,000 USD · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 2270d958-8c40-4649-96ab-ca716c957e74. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-01-31 · fmp

FY2028 EPS$5.62

$5.45 → $5.62 · observed estimates

FY2028 revenue$7.55B

$7.45B → $7.55B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$5.45	$7,445,029,447	5 / 7
2026-07-25	$5.45	$7,445,029,447	5 / 7
2026-07-26	$5.45	$7,445,029,447	5 / 7
2026-07-27	$5.45	$7,445,029,447	5 / 7
2026-07-28	$5.45	$7,445,029,447	5 / 7
2026-07-29	$5.45	$7,445,029,447	5 / 7
2026-07-30	$5.46	$7,446,229,447	5 / 7
2026-07-31	$5.46	$7,446,229,447	5 / 7
2026-08-01	$5.46	$7,446,229,447	5 / 7
2026-08-02	$5.46	$7,446,229,447	5 / 7
2026-08-03	$5.46	$7,446,229,447	5 / 7
2026-08-04	$5.46	$7,446,229,447	5 / 7
2026-08-05	$5.46	$7,446,229,447	5 / 7
2026-08-06	$5.46	$7,446,229,447	5 / 7
2026-08-08	$5.46	$7,446,229,447	5 / 7
2026-08-09	$5.46	$7,446,229,447	5 / 7
2026-08-10	$5.46	$7,446,229,447	5 / 7
2026-08-12	$5.46	$7,446,269,710	10 / 10
2026-08-13	$5.46	$7,446,229,447	5 / 7
2026-08-14	$5.46	$7,446,229,447	5 / 7
2026-08-15	$5.46	$7,446,229,447	5 / 7
2026-08-16	$5.46	$7,446,229,447	5 / 7
2026-08-17	$5.46	$7,446,229,447	5 / 7
2026-08-18	$5.46	$7,446,229,447	5 / 7
2026-08-19	$5.46	$7,446,229,447	5 / 7
2026-08-20	$5.59	$7,465,885,938	5 / 7
2026-08-21	$5.59	$7,465,885,938	6 / 7
2026-08-22	$5.59	$7,465,885,938	6 / 7
2026-08-23	$5.59	$7,465,885,938	6 / 7
2026-08-24	$5.59	$7,465,885,938	6 / 7
2026-08-25	$5.59	$7,465,935,068	6 / 7
2026-08-26	$5.59	$7,465,935,068	6 / 7
2026-08-27	$5.59	$7,465,935,068	6 / 7
2026-08-28	$5.59	$7,465,935,068	6 / 7
2026-08-29	$5.60	$7,467,635,068	6 / 7
2026-08-30	$5.60	$7,467,635,068	6 / 7
2026-08-31	$5.60	$7,467,635,068	6 / 7
2026-09-01	$5.60	$7,467,635,068	6 / 7
2026-09-02	$5.60	$7,467,635,068	6 / 7
2026-09-03	$5.60	$7,467,635,068	6 / 7
2026-09-04	$5.63	$7,508,404,970	6 / 7
2026-09-05	$5.57	$7,529,881,528	6 / 7
2026-09-06	$5.57	$7,529,881,528	6 / 7
2026-09-07	$5.57	$7,529,881,528	6 / 7
2026-09-08	$5.57	$7,529,881,528	6 / 7
2026-09-09	$5.61	$7,540,801,389	6 / 8
2026-09-10	$5.61	$7,540,801,389	6 / 8
2026-09-11	$5.61	$7,540,801,389	6 / 8
2026-09-12	$5.61	$7,540,801,389	6 / 8
2026-09-13	$5.62	$7,545,138,471	6 / 8
2026-09-14	$5.62	$7,545,138,471	6 / 8
2026-09-15	$5.62	$7,545,138,471	6 / 8
2026-09-16	$5.62	$7,545,138,471	6 / 8
2026-09-17	$5.62	$7,545,138,471	6 / 8
2026-09-18	$5.62	$7,545,138,471	6 / 8
2026-09-19	$5.62	$7,545,138,471	6 / 8
2026-09-20	$5.62	$7,545,093,017	6 / 8
2026-09-21	$5.62	$7,545,093,017	6 / 8
2026-09-22	$5.62	$7,545,093,017	6 / 8
2026-09-23	$5.62	$7,545,093,017	6 / 8
2026-09-24	$5.62	$7,545,093,017	6 / 8
2026-09-25	$5.62	$7,545,093,017	6 / 8
2026-09-26	$5.62	$7,545,093,017	6 / 8
2026-09-27	$5.62	$7,545,093,017	6 / 8
2026-09-28	$5.62	$7,545,093,017	6 / 8
2026-09-29	$5.62	$7,545,093,017	6 / 8
2026-09-30	$5.62	$7,545,093,017	6 / 8
2026-10-01	$5.62	$7,545,848,917	6 / 8
2026-10-02	$5.62	$7,545,848,917	6 / 8
2026-10-03	$5.62	$7,545,848,917	6 / 8
2026-10-04	$5.62	$7,545,848,917	6 / 8
2026-10-05	$5.62	$7,545,848,917	6 / 8
2026-10-06	$5.62	$7,545,848,917	6 / 8
2026-10-07	$5.62	$7,545,848,917	6 / 8
2026-10-08	$5.62	$7,545,848,917	6 / 8
2026-10-09	$5.62	$7,545,848,917	6 / 8
2026-10-10	$5.62	$7,545,848,917	6 / 8
2026-10-11	$5.62	$7,545,848,917	6 / 8
2026-10-12	$5.62	$7,545,848,917	6 / 8
2026-10-13	$5.62	$7,545,848,917	6 / 8
2026-10-14	$5.62	$7,545,848,917	6 / 8
2026-10-15	$5.62	$7,545,848,917	6 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	7	4
2026-06-01	7	5
2026-07-01	6	5
2026-08-01	6	5
2026-09-01	6	6
2026-10-01	6	6

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 6 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 16–Oct 15 · 1 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

EPS grows to at least $4.59 in FY27Direct metric needs a verified mapping
Operating profit near $565 million in FY27Operating margin: 15.95%
Revenue grows to at least $7.03 billion in FY27Revenue: $1.611B

Next proof point

Dec 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.1%Typical daily move · historical

Downside history

-27.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Victoria's Secret outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a durable compounder with a focus on growth through technology and digital innovation. The current thesis state is stable, supported by strong recent financial performance and management's commitment to growth strategies.

What's priced into Victoria's Secret

The market currently prices VSXY at a premium compared to its peers, reflecting justified expectations based on its recent performance. However, there is a slight expectations gap, indicating that some growth may already be factored into the valuation.

What the fundamentals likely do

Management's execution of its growth strategy appears on track, with raised guidance for both net sales and operating income. Recent financial results show strong growth, although there is a moderate risk of earnings surprises trending down.

What Victoria's Secret hinges on

The thesis hinges on several factors, including the potential for guidance cuts, inflation trends, and the performance of sector bellwethers. Positive momentum in the Consumer Discretionary sector could support VSXY, while unfavorable economic conditions could pose risks.